Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer

Related articles

1. Cyclin-dependent kinase 9 inhibitors as oncogene signaling modulators in combination with targeted therapy for the treatment of colorectal cancer

   This article has 16 authors:

   1. Mahshid Mohammadi
   2. Muzaffer Ahmed Bhat
   3. Terence Li
   4. Ning Wei
   5. Priyanka Patil
   6. Christiana Mo
   7. Natalie Thielen
   8. Zimo Huang
   9. Juan Du
   10. Doctor Yitzchak Goldstein
   11. Othon Wiltz
   12. Renee Huang
   13. Kohtaro Ooka
   14. Melanie Quintal
   15. Edward Chu
   16. Chaoyuan Kuang

2. DOT1L inhibition exerts anti-tumor effects by activating interferon signaling in breast cancer cells

   This article has 17 authors:

   1. Ayano Yoshido
   2. Kazuya Ishiguro
   3. Hiroshi Kitajima
   4. Takeshi Niinuma
   5. Kohei Kumegawa
   6. Masaki Maezawa
   7. Tomohide Tsukahara
   8. Mutsumi Toyota
   9. Akira Yorozu
   10. Hajime Sasaki
   11. Eiichiro Yamamoto
   12. Masahiro Kai
   13. Masashi Idogawa
   14. Toshihiko Torigoe
   15. Hiroshi Nakase
   16. Reo Maruyama
   17. Hiromu Suzuki

3. HSP90 inhibition induces selective destabilization of HDAC6 in a subset of tumor cell types

   This article has 5 authors:

   1. Zora Novakova
   2. Miroslava Vosahlikova
   3. Ruzena Tuckova
   4. Barbora Havlinova
   5. Cyril Barinka